The Regulation of Genetic Research and the Commercialisation of its Results in Finland
| Autor: | Laura Walin |
|---|---|
| Rok vydání: | 2006 |
| Předmět: | |
| Zdroj: | Medical Law International. 7:309-328 |
| ISSN: | 2047-9441 0968-5332 |
| DOI: | 10.1177/096853320600700402 |
| Popis: | The regulation of modern genetic research challenges the basic structures of Western legal systems, requiring new approaches and novel legal instruments. This article analyses the legislation adopted in Finland concerning biobanks, gene therapy, preimplantation genetic diagnosis, human cloning, embryo research and genetically modified organisms. An empirical survey of gene-related Finnish patents is also presented. In Finland, genetic research is regulated at four somewhat different but complementary levels. Parliamentary legislation, administrative control, professional self-regulation and public opinion operate together in the atmosphere of permissive technology-optimism. Of these, administrative control and professional self-control appear to be most important. Parliamentary legislation only provides rough guidelines and public discussion is rare and mildly toned. Whatever the mechanism for controlling genetic research, however, the reasons for such control can be derived from the protection of some basic right or freedom. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|